Human recombinant NACP/α-synuclein is aggregated and fibrillated in vitro: Relevance for Lewy body disease (Q46084408)
scientific article published on July 20, 1998
Language:
Current Data About Human recombinant NACP/α-synuclein is aggregated and fibrillated in vitro: Relevance for Lewy body disease
(P31) (Q13442814)
(P248)
(P698) 9675319
(P813) Tuesday, December 19, 2017
(P854) http://europepmc.org/abstract/MED/9675319

(P50) (Q28324209)
(P1545) 7
(P1932) Masliah E
(P248)
(P698) 9675319
(P813) Tuesday, December 19, 2017
(P854) http://europepmc.org/abstract/MED/9675319

(P304) 301-306
(P248)
(P698) 9675319
(P813) Tuesday, December 19, 2017
(P854) http://europepmc.org/abstract/MED/9675319

(P407) (Q1860)

(P433) 2
(P248)
(P698) 9675319
(P813) Tuesday, December 19, 2017
(P854) http://europepmc.org/abstract/MED/9675319

(P478) 799
(P248)
(P698) 9675319
(P813) Tuesday, December 19, 2017
(P854) http://europepmc.org/abstract/MED/9675319

(P577) Wednesday, July 1, 1998
(P248)
(P698) 9675319
(P813) Tuesday, December 19, 2017
(P854) http://europepmc.org/abstract/MED/9675319

Monday, July 20, 1998
(P248)
(P698) 9675319
(P854) https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=9675319
(P813) Wednesday, January 1, 2025

(P921) (Q24767155)
(P887)

(P953) https://api.elsevier.com/content/article/PII:S0006899398005149?httpAccept=text/xml
(P248)
(P356) 10.1016/S0006-8993(98)00514-9
(P854) https://api.crossref.org/works/10.1016/S0006-8993(98)00514-9
(P813) Wednesday, January 1, 2025

https://api.elsevier.com/content/article/PII:S0006899398005149?httpAccept=text/plain
(P248)
(P356) 10.1016/S0006-8993(98)00514-9
(P854) https://api.crossref.org/works/10.1016/S0006-8993(98)00514-9
(P813) Wednesday, January 1, 2025

(P1433) (Q4955782)
(P248)
(P698) 9675319
(P813) Tuesday, December 19, 2017
(P854) http://europepmc.org/abstract/MED/9675319

(P1476) "Human recombinant NACP/alpha-synuclein is aggregated and fibrillated in vitro: relevance for Lewy body disease" (language: en)
(P248)
(P698) 9675319
(P813) Tuesday, December 19, 2017
(P854) http://europepmc.org/abstract/MED/9675319

"Human recombinant NACP/α-synuclein is aggregated and fibrillated in vitro: Relevance for Lewy body disease" (language: en)
(P248)
(P356) 10.1016/S0006-8993(98)00514-9
(P854) https://api.crossref.org/works/10.1016/S0006-8993(98)00514-9
(P813) Wednesday, January 1, 2025

(P2093) M. Hashimoto
(P1545) 1
(P248)
(P698) 9675319
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9675319
(P813) Wednesday, January 1, 2025

L. J. Hsu
(P1545) 2
(P248)
(P698) 9675319
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9675319
(P813) Wednesday, January 1, 2025

A. Sisk
(P1545) 3
(P248)
(P698) 9675319
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9675319
(P813) Wednesday, January 1, 2025

Y. Xia
(P1545) 4
(P248)
(P698) 9675319
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9675319
(P813) Wednesday, January 1, 2025

A. Takeda
(P1545) 5
(P248)
(P698) 9675319
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9675319
(P813) Wednesday, January 1, 2025

M. Sundsmo
(P1545) 6
(P248)
(P698) 9675319
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9675319
(P813) Wednesday, January 1, 2025

(P2860) (Q28571915)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900514-9
(P813) Thursday, January 7, 2021

(Q46754143)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900514-9
(P813) Thursday, January 7, 2021

(Q68173181)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900514-9
(P813) Thursday, January 7, 2021

(Q27734827)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900514-9
(P813) Thursday, January 7, 2021

(Q40397157)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900514-9
(P813) Thursday, January 7, 2021

(Q34303003)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900514-9
(P813) Thursday, January 7, 2021

(Q73909478)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900514-9
(P813) Thursday, January 7, 2021

(Q46497529)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900514-9
(P813) Thursday, January 7, 2021

(Q41092684)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900514-9
(P813) Thursday, January 7, 2021

(Q34318718)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900514-9
(P813) Thursday, January 7, 2021

(Q46357266)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900514-9
(P813) Thursday, January 7, 2021

(Q34341909)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900514-9
(P813) Thursday, January 7, 2021

(Q40918121)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900514-9
(P813) Thursday, January 7, 2021

(Q24530132)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900514-9
(P813) Thursday, January 7, 2021

(Q29547175)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900514-9
(P813) Thursday, January 7, 2021

(Q36455215)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900514-9
(P813) Thursday, January 7, 2021

(Q33240068)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900514-9
(P813) Thursday, January 7, 2021

(Q27860459)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900514-9
(P813) Thursday, January 7, 2021

(Q27860680)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900514-9
(P813) Thursday, January 7, 2021

(Q24321355)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900514-9
(P813) Thursday, January 7, 2021

(Q36830682)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900514-9
(P813) Thursday, January 7, 2021

(Q30470224)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900514-9
(P813) Thursday, January 7, 2021

(Q33888339)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900514-9
(P813) Thursday, January 7, 2021

(Q40486855)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900514-9
(P813) Thursday, January 7, 2021
(P887)

(Q28304249)
(P1545) 16
(P248)
(P356) 10.1016/S0006-8993(98)00514-9
(P854) https://api.crossref.org/works/10.1016/S0006-8993(98)00514-9
(P813) Wednesday, January 1, 2025

(Q35773886)
(P1545) 21
(P248)
(P356) 10.1016/S0006-8993(98)00514-9
(P854) https://api.crossref.org/works/10.1016/S0006-8993(98)00514-9
(P813) Wednesday, January 1, 2025

other details
aliases Human recombinant NACP/α-synuclein is aggregated and fibrillated in vitro: Relevance for Lewy body disease
description scientific article published on July 20, 1998

External Links
(P356) 10.1016/S0006-8993(98)00514-9
(P698) 9675319